Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKBA | TAK | ZTS | GRFS | NBIX |
| Company | Akebia Therapeutics | Takeda Pharmaceutical Ltd ADR | Zoetis Inc Cl A | Grifols S.A. ADR | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 1.4100 | 13.41 | 167.35 | 6.98 | 140.55 |
| High | 1.4600 | 13.41 | 167.62 | 7.08 | 143.57 |
| Low | 1.4000 | 13.34 | 165.26 | 6.93 | 140.55 |
| Last | 1.4350 | 13.34 | 165.36 | 7.06 | 142.41 |
| Change | +0.0650 | -0.03 | -1.71 | +0.49 | +1.70 |
| % Change | +4.74% | -0.22% | -1.02% | +7.46% | +1.21% |
| Volume | 1,052,496 | 443,710 | 888,147 | 1,173,113 | 140,592 |
| 20-Day Average Volume | 2,989,666 | 1,537,043 | 4,499,777 | 1,325,342 | 779,090 |
| Previous Close | 1.3700 | 13.37 | 167.07 | 6.57 | 140.71 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.3863 | 13.28 | 156.65 | 6.58 | 136.94 |
| 20-Day Raw Stochastic | 56.79% | 50.38% | 78.91% | 74.93% | 79.41% |
| 20-Day Relative Strength | 48.81% | 43.63% | 51.85% | 53.36% | 56.50% |
| Weighted Alpha | +8.24 | -18.44 | -11.17 | +0.36 | +47.18 |
| Today's Opinion | 24% Buy | 88% Sell | 56% Sell | 64% Sell | 88% Buy |
| Previous Opinion | 8% Buy | 88% Sell | 56% Sell | 100% Sell | 88% Buy |
| Last Month's Opinion | 64% Buy | 88% Sell | 56% Sell | 88% Sell | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.47% since 04/29/24 | +1.37% since 04/29/24 | +3.96% since 04/29/24 | +8.67% since 04/29/24 | +2.32% since 04/29/24 |
| Low | 1.2150 on 05/02/24 | 13.08 on 05/01/24 | 158.04 on 05/01/24 | 6.32 on 04/30/24 | 136.01 on 05/01/24 |
| High | 1.4600 on 05/06/24 | 13.41 on 05/06/24 | 171.69 on 05/03/24 | 7.07 on 05/06/24 | 145.22 on 05/01/24 |
| 1-Month | |||||
| %Chg | -3.02% since 04/05/24 | -1.98% since 04/05/24 | +0.10% since 04/05/24 | -0.68% since 04/05/24 | +2.30% since 04/05/24 |
| Low | 1.2150 on 05/02/24 | 13.01 on 04/26/24 | 144.80 on 04/22/24 | 6.12 on 04/25/24 | 130.13 on 04/19/24 |
| High | 1.6200 on 04/10/24 | 13.77 on 04/08/24 | 171.69 on 05/03/24 | 7.35 on 04/09/24 | 145.22 on 05/01/24 |
| 3-Month | |||||
| %Chg | -13.99% since 02/06/24 | -5.72% since 02/06/24 | -15.36% since 02/06/24 | -16.07% since 02/06/24 | -0.59% since 02/06/24 |
| Low | 1.2150 on 05/02/24 | 13.01 on 04/26/24 | 144.80 on 04/22/24 | 5.30 on 03/06/24 | 128.00 on 02/07/24 |
| High | 2.4800 on 03/28/24 | 14.88 on 02/27/24 | 200.53 on 02/29/24 | 9.37 on 02/28/24 | 148.37 on 03/21/24 |
| 6-Month | |||||
| %Chg | +44.50% since 11/06/23 | -2.63% since 11/06/23 | +1.75% since 11/06/23 | -23.13% since 11/06/23 | +24.65% since 11/06/23 |
| Low | 0.8800 on 11/13/23 | 13.01 on 04/26/24 | 144.80 on 04/22/24 | 5.30 on 03/06/24 | 103.63 on 11/10/23 |
| High | 2.4800 on 03/28/24 | 15.07 on 01/12/24 | 201.92 on 12/14/23 | 12.15 on 12/29/23 | 148.37 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 286,840 | 42,313,872 | 76,410,976 | 4,517,270 | 14,160,632 |
| Shares Outstanding, K | 209,372 | 3,164,837 | 457,359 | 687,560 | 100,637 |
| Annual Sales | 194,620,000 | 29,803,340,000 | 8,544,000,000 | 7,134,500,000 | 1,887,100,000 |
| Annual Net Income | -51,930,000 | 2,345,930,000 | 2,344,000,000 | 64,200,000 | 249,700,000 |
| Last Quarter Sales | 56,070,000 | 7,556,070,000 | 2,213,000,000 | 2,025,030,000 | 515,200,000 |
| Last Quarter Net Income | -50,000 | 718,900,000 | 525,000,000 | 58,780,000 | 147,700,000 |
| 60-Month Beta | 0.94 | 0.56 | 0.86 | 0.57 | 0.28 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 03/14/24 | 0.51 on 02/01/24 | 1.38 on 05/02/24 | 0.09 on 07/27/23 | 0.42 on 05/01/24 |
| Latest Earnings Date | 05/09/24 | 05/09/24 | 05/02/24 | 03/05/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.261 on 09/28/23 | 0.432 on 04/18/24 | 0.370 on 06/03/21 | N/A |
| Next Ex-Dividends Date | N/A | 09/28/23 | 04/18/24 | 06/03/21 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.81 | 31.03 | 0.00 | 38.52 |